India, Sept. 6 -- AstraZeneca, a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines, has announced a strategic investment of Rs 176 crore, the third such investment in the past two years in India.

This new investment is focused on expanding the capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai to strengthen its position as a leader in healthcare innovation both globally and in India.

AstraZeneca's expanded presence in the country will fuel the development of advanced technology capabilities, foster high-value job creation, and deepen collaborations with local talent pools and partners in Tamil Nadu and India. Additiona...